A Case Series of Multiple Primary Malignancies Among Patients With Advanced Melanoma
Open Access
- 6 June 2021
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 13 (6) , e15480
Abstract
Multiple primary malignancies (MPM) are described as two or more primary tumors within the same individual. The impact of MPM on the tumor microenvironment among patients with melanoma is poorly understood. Here, we describe this unique group of patients who have both advanced melanoma and at least one other primary malignancy and report their survival outcomes. In this study, patients with advanced melanoma and a second primary malignancy were identified. Medical records were reviewed for cancer treatment history. Kaplan-Meier methods were used to derive survival curves and estimate overall survival (OS), and log-rank tests were used to compare OS. Among 11 MPM patients, the most common non-melanoma cancers were breast (n = 3) and thyroid (n = 3). Median OS was 153.5 months for all patients. Median OS for synchronous MPM (sMPM) and metachronous MPM (mMPM) were 83.1 and 196.7 months, respectively (p = 0.10). Median OS was not reached when melanoma was diagnosed first, and 153.5 months when diagnosed second (p = 0.45). For six patients receiving immunotherapy for melanoma, there was a 100% complete response rate. In conclusion, patients with melanoma are at risk of secondary malignancies, including breast and thyroid cancer. The timing of secondary malignancies may impact prognosis. Further study of the impact of immunotherapy on MPM is warranted.Keywords
This publication has 25 references indexed in Scilit:
- Germline genetic contribution to the immune landscape of cancerImmunity, 2021
- The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort studyBMC Cancer, 2020
- Multiple Primary Tumors Over a Lifetime.2019
- Prevalence of Homologous Recombination–Related Gene Mutations Across Multiple Cancer TypesJCO Precision Oncology, 2018
- Causes of death among cancer patientsAnnals of Oncology, 2016
- Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomasJournal of the American Academy of Dermatology, 2016
- Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanomaJournal of Clinical Investigation, 2010
- Clinicopathologic Features of Metachronous or Synchronous Gastric Cancer Patients with Three or More Primary SitesCancer Research and Treatment, 2010
- Mechanisms of local immunosuppression in cutaneous melanomaBritish Journal of Cancer, 2007
- Risk of second primary malignancies in patients with cutaneous melanomaBritish Journal of Dermatology, 2001